Recently, Koike et al. [145] demonstrated that the BDNF/TrkB signaling pathways may be involved in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist on tail suspension and the novelty-suppressed feeding models of depression. The gene discussed is BDNF; the disease is major depressive disorder.